» Articles » PMID: 18059697

Rapid Near-infrared Raman Spectroscopy System for Real-time in Vivo Skin Measurements

Overview
Journal Opt Lett
Specialty Ophthalmology
Date 2007 Dec 7
PMID 18059697
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

A rapid dispersive-type near-infrared (NIR) Raman spectroscopy system and a Raman probe were developed to facilitate real-time, noninvasive, in vivo human skin measurements. Spectrograph image aberration was corrected by a parabolic-line fiber array, permitting complete CCD vertical binning, thereby yielding a 3.3-16-fold improvement in signal-to-noise ratio. Good quality in vivo cutaneous NIR Raman spectra free of interference from fiber fluorescence and silica Raman scattering can be acquired in less than 1 s, which greatly facilitates practical noninvasive tissue characterization and clinical diagnosis.

Citing Articles

Label-Free Fiber-Optic Raman Spectroscopy for Intravascular Coronary Atherosclerosis and Plaque Detection.

Jia H, Chen X, Shen J, Liu R, Hou P, Yue S ACS Omega. 2024; 9(26):27789-27797.

PMID: 38973848 PMC: 11223210. DOI: 10.1021/acsomega.4c01611.


Improving skin cancer detection by Raman spectroscopy using convolutional neural networks and data augmentation.

Zhao J, Lui H, Kalia S, Lee T, Zeng H Front Oncol. 2024; 14:1320220.

PMID: 38962264 PMC: 11219827. DOI: 10.3389/fonc.2024.1320220.


Accurate and rapid molecular subgrouping of high-grade glioma via deep learning-assisted label-free fiber-optic Raman spectroscopy.

Liu C, Wang J, Shen J, Chen X, Ji N, Yue S PNAS Nexus. 2024; 3(6):pgae208.

PMID: 38860145 PMC: 11164103. DOI: 10.1093/pnasnexus/pgae208.


Portable System for In-Clinic Differentiation of Skin Cancers from Benign Skin Lesions and Inflammatory Dermatoses.

Nieuwoudt M, Jarrett P, Matthews H, Locke M, Bonesi M, Burnett B JID Innov. 2024; 4(1):100238.

PMID: 38274304 PMC: 10808988. DOI: 10.1016/j.xjidi.2023.100238.


Diagnostics Using Non-Invasive Technologies in Dermatological Oncology.

Soglia S, Perez-Anker J, Lobos Guede N, Giavedoni P, Puig S, Malvehy J Cancers (Basel). 2022; 14(23).

PMID: 36497368 PMC: 9738560. DOI: 10.3390/cancers14235886.